The most plausible mechanism is the inhibition of cyclin-dependent kinase inhibitor, such as p21 and p27, whose expression is differently modulated by 1,25(OH)2D, therefore blocking the cell cycle progression in S phase in prostate [157] and breast cancer [134,151] cell lines. Here, CDKN1A is linked to breast cancer.